Loading news...
NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Marex Group plc (‘Marex', NASDAQ: MRX), the diversified global financial services platform, provides details for its upcoming Investor Day being held at the Nasdaq MarketSite in New York on March 26, 2026. The event will feature presentations from Ian Lowitt, CEO, Rob Irvin, CFO, and other senior leadership.
Five of the Royce SMid-Cap Total Return Fund portfolio's nine equity sectors made a positive impact on calendar year performance. In the post-Covid era, airlines have seen a significant resurgence in passenger demand, which engine OEMs (original equipment manufacturers) have struggled to meet amid quality issues with new engine families such as the LEAP and GTF. Sapiens has idiosyncratic opportunities to drive growth and profitability through new geographies, expanding the product suite into adjacent areas, and scaling up existing operations.
Marex Group is upgraded to a Buy following robust Q4 2025 results and strong momentum with large clients. MRX reported Q4 revenue up 38% to $572.1M and EPS up 50% to $1.14, exceeding expectations and driving 41.9% FY EPS growth. Agency/Execution segment now generates more revenue than the other three segments combined, with large-client revenue up 83% year-on-year.
Marex Group plc (MRX) Q4 2025 Earnings Call Transcript
Marex Group PLC (MRX) came out with quarterly earnings of $1.12 per share, beating the Zacks Consensus Estimate of $1.02 per share. This compares to earnings of $0.76 per share a year ago.
NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Marex Group plc (‘Marex' or the ‘Group'; Nasdaq: MRX) a diversified global financial services platform, providing essential liquidity, market access and infrastructure services to clients in the energy, commodities and financial markets, today reported the Group's preliminary unaudited financial results for the fourth quarter ('Q4 2025'). Ian Lowitt, Group Chief Executive Officer, stated, “This was a record fourth quarter for Marex, marked by a strong, broad-based performance, supportive market conditions and high levels of client activity.
Does Marex Group PLC (MRX) have what it takes to be a top stock pick for momentum investors? Let's find out.
The average of price targets set by Wall Street analysts indicates a potential upside of 28.5% in Marex Group PLC (MRX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Marex Group plc (NASDAQ: MRX).
LOS ANGELES, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Marex Group plc, (“Marex” or the "Company") (NASDAQ: MRX) investors off a class action on behalf of investors that bought securities between May 16, 2024 and August 5, 2025, inclusive (the “Class Period”). Marex investors have until December 8, 2025 to file a lead plaintiff motion.
NEW YORK--(BUSINESS WIRE)---- $MRX #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Marex Group plc (“Marex” or the “Company”) (NASDAQ: MRX) and reminds investors of the December 8, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has.
LOS ANGELES, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
LOS ANGELES, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Marex Group plc (“Marex” or “the Company”) (NASDAQ: MRX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 16, 2024 and August 5, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before December 8, 2025.
NEW YORK , Dec. 8, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Marex Group plc (NASDAQ: MRX). Shareholders who purchased shares of MRX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
LOS ANGELES , Dec. 8, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Marex Group plc ("Marex" or "the Company") (NASDAQ: MRX ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of MRX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.
LOS ANGELES , Dec. 8, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Marex Group plc ("Marex" or "the Company") (NASDAQ: MRX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 16, 2024 and August 5, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before December 8, 2025.
New York, New York--(Newsfile Corp. - December 7, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Marex Group plc (NASDAQ: MRX) between May 16, 2024 and August 5, 2025, both dates inclusive (the "Class Period"), of the important December 8, 2025 lead plaintiff deadline. SO WHAT: If you purchased Marex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
NEW YORK, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Marex Group plc (“Marex” or “the Company”) (NASDAQ: MRX) and certain of its officers.
NEW YORK , Dec. 7, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Marex Group plc (NASDAQ: MRX) between May 16, 2024 and August 5, 2025, both dates inclusive (the "Class Period"), of the important December 8, 2025 lead plaintiff deadline. So what: If you purchased Marex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in Marex to Contact Him Directly to Discuss Their Options If you purchased or acquired securities in Marex between May 16, 2024 and August 5, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - December 7, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Marex Group plc ("Marex" or the "Company") (NASDAQ: MRX) and reminds investors of the December 8, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.